| Page 171 | Aplastic Anemia and MDS International Foundation

Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Author(s): 
Fey MF, Dreyling M; ESMO Guidelines Working Group
Primary Author: 
Fey MF
Journal Title: 
Ann Oncol
Original Publication Date: 
May 2010

No abstract available.

Bone Marrow Diseases: 

5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline.

Author(s): 
Buckstein R, Yee K, Wells RA; Canadian Consortium on Evidence-based Care in MDS.
Primary Author: 
Buckstein R
Journal Title: 
Cancer Treat Rev
Original Publication Date: 
Jun 2010

BACKGROUND:

Myelodysplastic syndrome (MDS) is a clonal disorder of hematopoiesis that results in peripheral blood cytopenias

Bone Marrow Diseases: 

Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes.

Author(s): 
Greenberg PL, Koller CA, Cabantchik ZI, Warsi G, Glynos T, Paley C, Schiffer C
Primary Author: 
Greenberg PL
Journal Title: 
Leuk Res
Original Publication Date: 
Jul 2010

We report the first prospective study evaluating the effects of

Bone Marrow Diseases: